Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

por Manitz, Juliane, D'Angelo, Sandra P, Apolo, Andrea B, Eggleton, S Peter, Bajars, Marcis, Bohnsack, Oliver, Gulley, James L
Publicado 2022

TRLS-03. Intracranial activity of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC enrolled in VISION

por Bestvina, Christine M, Le, Xiuning, Veillon, Remi, Anderson, Ian, Patel, Jyoti, Demedts, Ingel, Garassino, Marina, Mazières, Julien, Morise, Masahiro, Smit, Egbert, Eggleton, S Peter, O’Brate, Aurora, Otto, Gordon, Bruns, Rolf, Schumacher, Karl Maria, Paik, Paul
Publicado 2021

SYST-06 INTRACRANIAL ACTIVITY OF TEPOTINIB IN PATIENTS WITH MET EXON 14 (METEX14) SKIPPING NSCLC ENROLLED IN VISION

por Leighl, Natasha, Bestvina, Christine, Patel, Jyoti, Le, Xiuning, Veillon, Remi, Anderson, Ian, Demedts, Ingel, Garassino, Marina Chiara, Mazières, Julien, Morise, Masahiro, Smit, Egbert, Eggleton, S Peter, O’Brate, Aurora, Otto, Gordon, Bruns, Rolf, Schumacher, Karl Maria, Paik, Paul
Publicado 2022

Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Can...

por Qin, Shukui, Li, Jin, Wang, Liwei, Xu, Jianming, Cheng, Ying, Bai, Yuxian, Li, Wei, Xu, Nong, Lin, Li-zhu, Wu, Qiong, Li, Yunfeng, Yang, Jianwei, Pan, Hongming, Ouyang, Xuenong, Qiu, Wensheng, Wu, Kaichun, Xiong, Jianping, Dai, Guanghai, Liang, Houjie, Hu, Chunhong, Zhang, Jun, Tao, Min, Yao, Qiang, Wang, Junyuan, Chen, Jiongjie, Eggleton, S. Peter, Liu, Tianshu
Publicado 2018